Generating multispecific antibody mixtures and methods of uses thereof

Patent metadata

Field	Value
Publication number	US-11401299-B2
Application number	US-201816042889-A
Country	US
Kind code	B2
Filing date	Jul 23, 2018
Priority date	Jul 21, 2017
Publication date	Aug 2, 2022
Grant date	Aug 2, 2022

Abstract

The invention relates to the generation of multispecific antibody mixtures include a subset of antibodies isolated from a mixture of two or more monospecific antibodies and one or more bispecific antibodies, wherein all antibodies in the subset have the same common heavy chain. The invention also relates to methods of isolating, purifying, or otherwise producing such a subset of antibodies by using at least one affinity chromatography step. The invention also relates to methods of using such a subset of antibodies in a variety of therapeutic indications.

First claim

What is claimed is:

1. A method of isolating a subset of antibodies:
a. culturing a single cell line capable of expressing:
i. one immunoglobulin heavy chain; and
ii. at least three immunoglobulin light chains wherein at least one light chain is a kappa light chain and at least one light chain is a lambda light chain

to produce an antibody mixture of three or more monospecific antibodies and three or more bispecific antibodies;
b. purifying a subset of antibodies from the antibody mixture by at least two affinity chromatography steps, wherein the at least two affinity purification steps include a purification step using a protein A affinity chromatography media followed by:
i. a kappa constant domain specific affinity chromatography media; or
ii. a lambda constant specific affinity chromatography media, or
iii. a combination of the affinity chromatography media of (i) and (ii), wherein the affinity chromatography media of (i) and (ii) are used in any order, thereby isolating a subset of antibodies,

1) wherein when the single cell line expresses:
a) an immunoglobulin light chain comprising at least a portion of a kappa light chain and two immunoglobulin light chains comprising at least a portion of a lambda light chain; or
b) an immunoglobulin light chain comprising at least a portion of a lambda light chain and two immunoglobulin light chains comprising at least a portion of a kappa light chain,

the purifying of a subset of antibodies from the antibody mixture is performed using:
I) kappa constant domain specific affinity chromatography media, wherein the purified subset of antibodies consists of:
i) one monospecific antibody and two bispecific antibodies; or
ii) two monospecific antibodies and three bispecific antibodies;
all comprising at least a portion of a kappa light chain; or
II) lambda constant domain specific affinity chromatography media, wherein the purified subset of antibodies consists of:
i) one monospecific antibody and two bispecific antibodies; or
ii) two monospecific antibodies and three bispecific antibodies; all comprising at least a portion of a lambda light chain; or
III) kappa constant domain specific affinity chromatography media and lambda constant specific affinity chromatography media, wherein the purified subset of antibodies consists of two bispecific antibodies all comprising at least a portion of a kappa light chain and at least a portion of a lambda light chain; or

2) wherein when the single cell line expresses:
a) an immunoglobulin light chain comprising at least a portion of a kappa light chain and three immunoglobulin light chains comprising at least a portion of a lambda light chain; or
b) an immunoglobulin light chain comprising at least a portion of a lambda light chain and three immunoglobulin light chains comprising at least a portion of a kappa light chain; or
c) two immunoglobulin light chains comprising at least a portion of a kappa light chain and two immunoglobulin light chains comprising at least a portion of a lambda light chain;

the purifying a subset of antibodies is performed using:
I) kappa constant domain specific affinity chromatography media, wherein the purified subset of antibodies consists of:
i) one monospecific antibody and three bispecific antibodies; or
ii) three monospecific antibodies and six bispecific antibodies; or
iii) two monospecific antibodies and five bispecific antibodies;
all comprising at least a portion of a kappa light chain; or
II) lambda constant domain specific affinity chromatography media wherein the purified subset of antibodies consists of:
i) one monospecific antibody and three bispecific antibodies; or
ii) three monospecific antibodies and six bispecific antibodies; or
iii) two monospecific antibodies and five bispecific antibodies;
all comprising at least a portion of a lambda light chain; or
III) kappa constant domain specific affinity chromatography media and lambda constant specific affinity chromatography media, wherein the purified subset of antibodies consists of three or four bispecific antibodies all comprising at least a portion of a kappa light chain and at least a portion of a lambda light chain.

2. The method of claim 1 , wherein the subset of antibodies comprise both monospecific and bispecific antibodies.

3. The method of claim 1 , wherein the subset of antibodies comprises an antibody that binds a different epitope of the same antigen.

Assignees

• Novimmune Sa

Inventors

• Fischer Nicolas
• Magistrelli Giovanni
• Masternak Krzysztof

Classifications

• C07K16/00 Primary

  Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies · CPC title

• C07K16/2803

  against the immunoglobulin superfamily · CPC title

• C07K16/468

  Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies · CPC title

• A61K2039/505

  comprising antibodies · CPC title

• C07K2317/51

  Complete heavy chain or Fd fragment, i.e. VH + CH1 · CPC title